COST-EFFECTIVENESS ANALYSIS OF SACUBITRIL/VALSARTAN COMPARED WITH STANDARD ACEI THERAPIES FOR HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION IN TAIWAN

被引：1
|
作者：
Fann, C. [1 ]
Chen, S. [2 ]
机构：
[1] Kainan Univ, Taoyuan, Taiwan
[2] Novartis Taiwan, Taipei, Taiwan
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1239
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV93
引用
收藏
页码：A617 / A617
页数：1
相关论文
共 50 条
  • [31] Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context
    D'Angiolella, Lucia S.
    Cortesi, Paolo A.
    Pitotti, Claudia
    Ritrovato, Daniela
    Mantovani, Lorenzo G.
    Senni, Michele
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (11) : 1551 - 1553
  • [32] The cost-effectiveness of sacubitril/valsartan (LCZ696) in the treatment of patients with heart failure with reduced ejection fraction in Norway
    Gundersen, V.
    Eklund, O.
    Hancock, E.
    Hussain, R.
    Ohna, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 203 - 203
  • [33] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN (FORMERLY LCZ696) IN CHRONIC HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION - AN ANALYSIS FOR SWITZERLAND
    Ademi, Z.
    Hancock, E.
    Trueman, D.
    Pfeil, A.
    Haroun, R.
    Deschaseaux, C.
    Schwenkglenks, M.
    VALUE IN HEALTH, 2016, 19 (07) : A655 - A655
  • [34] THE COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN ALTERNATIVE AGE GROUPS
    Hancock, E.
    Trueman, D.
    Alexopoulos, S. T.
    Gielen, V
    VALUE IN HEALTH, 2016, 19 (07) : A655 - A655
  • [35] REAL-WORLD COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN SYMPTOMATIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN PORTUGAL
    Afonso-Silva, M.
    Laires, P. A.
    VALUE IN HEALTH, 2019, 22 : S545 - S545
  • [36] Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction With a Recent Worsening Heart Failure Event
    Dixit, Neal
    Truong, Katie
    Ziaeian, Boback
    Fonarow, Gregg C.
    CIRCULATION, 2023, 148
  • [37] Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared to Enalapril for Heart Failure Patients in Indonesia
    Zakiyah, Neily
    Sinuraya, Rano K.
    Kusuma, Arif S. W.
    Suwantika, Auliya
    Lestari, Keri
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 863 - 872
  • [38] THE COST EFFECTIVENESS OF SACUBITRIL/VALSARTAN FOR THE TREATMENT OF CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION IN KOREA
    Lee, J.
    Ko, S.
    VALUE IN HEALTH, 2017, 20 (09) : A617 - A618
  • [39] Cost-Utility Analysis of Sacubitril/Valsartan Use Compared With Standard Care in Chronic Heart Failure Patients With Reduced Ejection Fraction in South Korea
    Park, Sun-Kyeong
    Hong, Sung-Hyun
    Kim, HyoJin
    Kim, Sungju
    Lee, Eui-Kyung
    CLINICAL THERAPEUTICS, 2019, 41 (06) : 1066 - 1079
  • [40] Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
    Dewan, Pooja
    Docherty, Kieran F.
    McMurray, John J., V
    KOREAN CIRCULATION JOURNAL, 2019, 49 (06) : 469 - 484
12345